Literature DB >> 17292512

Abeta(1-42) modulation of Akt phosphorylation via alpha7 nAChR and NMDA receptors.

Jonathan J Abbott1, David R Howlett, Paul T Francis, Robert J Williams.   

Abstract

Elevated Abeta and its deposition as senile plaques are pathogenic features of Alzheimer's disease. Abeta has been shown to be toxic to neurons and to inhibit long-term potentiation yet, the intracellular signalling pathways underlying these actions are unknown. We report for the first time that acute exposure of primary mouse neurons to 400nM Abeta(1-42) increased Akt phosphorylation in an alpha(7) nicotinic receptor and NMDA receptor dependant manner. However, prolonged incubation resulted in Akt phosphorylation returning to baseline consistent with the action of a physiological regulator. Analysis of an APP transgenic mouse (TAS10) revealed a significant deficit in hippocampal Akt phosphorylation at 13 months. This time point corresponds to the emergence of plaque formation and memory impairments in these mice. The present study suggests that Abeta(1-42) regulates Akt phosphorylation in a complex manner. Acutely, Abeta(1-42) stimulates Akt phosphorylation however, chronic exposure to Abeta in TAS10 mice resulted in a downregulation of Akt phosphorylation consistent with abnormalities in excitatory neurotransmission in these mice and with recent reports of Abeta(1-42) driven internalisation of NMDA receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292512     DOI: 10.1016/j.neurobiolaging.2007.01.003

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  26 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

Review 2.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture.

Authors:  Natasha Bajic; Peter Jenner; Clive G Ballard; Paul T Francis
Journal:  J Neural Transm (Vienna)       Date:  2012-05-17       Impact factor: 3.575

Review 4.  Alzheimer's disease amyloid beta-protein and synaptic function.

Authors:  Tomas Ondrejcak; Igor Klyubin; Neng-Wei Hu; Andrew E Barry; William K Cullen; Michael J Rowan
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

5.  PI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila.

Authors:  Hsueh-Cheng Chiang; Lei Wang; Zuolei Xie; Alice Yau; Yi Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

Review 6.  Crosstalk between the mTOR and Nrf2/ARE signaling pathways as a target in the improvement of long-term potentiation.

Authors:  Artem P Gureev; Vasily N Popov; Anatoly A Starkov
Journal:  Exp Neurol       Date:  2020-03-10       Impact factor: 5.330

Review 7.  A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease.

Authors:  Renato X Santos; Sónia C Correia; Xinglong Wang; George Perry; Mark A Smith; Paula I Moreira; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

8.  mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.

Authors:  Han-Kyu Lee; Bumsup Kwon; Cynthia A Lemere; Suzanne de la Monte; Kyohei Itamura; Austin Y Ha; Henry W Querfurth
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Cross-species analysis of nicotine-induced proteomic alterations in pancreatic cells.

Authors:  Darwin L Conwell; Hanno Steen; Joao A Paulo; Raul Urrutia; Vivek Kadiyala; Peter Banks
Journal:  Proteomics       Date:  2013-05       Impact factor: 3.984

10.  Aging of the NMDA receptor: from a mouse's point of view.

Authors:  Kathy R Magnusson
Journal:  Future Neurol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.